Aquatic Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Aquatic Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-113,623	Closed	-$1.68M	–	1258
2026 Q1	$1.68M	Buy	+113,623	New	+$1.66M	0.05%	422
2025 Q4	–	Sell	-41,516	Closed	-$459K	–	1400
2025 Q3	$459K	Buy	41,516 +6,556	+19%	+$71.6K	0.01%	885
2025 Q2	$296K	Buy	+34,960	New	+$280K	0.01%	948
2023 Q2	–	Sell	-13,200	Closed	-$145K	–	1325
2023 Q1	$145K	Buy	+13,200	New	+$116K	0.01%	664
2022 Q3	–	Sell	-19,200	Closed	-$193K	–	1173
2022 Q2	$193K	Buy	19,200 +19,000	+9,500%	+$212K	0.06%	347
2022 Q1	$2K	Buy	+200	New	+$3.09K	﹤0.01%	953

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's AUPH Position: Q2 2026 in Review

Aquatic Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 113,623 shares — an estimated $1.68M sold.

Aquatic Capital Management first reported a position in AUPH in Q1 2022 and held it in 6 quarters. The position peaked at $1.68M in Q1 2026. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Aquatic Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Aquatic Capital Management sold 113,623 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $1.68M.
Aquatic Capital Management first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 6 quarters.
Aquatic Capital Management's Aurinia Pharmaceuticals position peaked at $1.68M in Q1 2026.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.